VeroVaccines raises €3.2M Pre-Seed round
1 January 2013· Halle (Saale), Germany· health, biotech, b2b, deep_hardware
Initial academic phase of the GO-Bio project to develop inexpensive and highly effective vaccines using lactic yeast
Investors
LeadGO-Bio
About VeroVaccines
Stage
Bridge
Headquarters
Halle (Saale), Germany
Founded
2021
Team Size
6–20
Sectors
healthbiotechb2bdeep_hardware
Source: https://www.campus-halensis.de/artikel/verovaccines-impfstoffentwickler-auf-erfolgskurs/